Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

2049-80-1

应用筛选条件
关键词:'2049-80-1'
显示 1-30 共 161 条结果 关于 "2049-80-1" 范围 技术文档
AMER1 Hu-Cy3 SmartFlare™ RNA Detection Probe
control SmartFlare (Figure 1). For additional accession numbers predicted to react with this SmartFlare Probe, please visit http://www.millipore.com/catalogue/item/SF- 2049
Product Information Sheet - SM2021
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0421
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0121
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SHXC01
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SHX001
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130- 2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0411
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0431
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM2011
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0111
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM2031
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - SM0131
enquiries@oxfordbiomedica.co.uk or BioMedica Inc., 11622 El Camino Real #100, San Diego CA 92130-2049 USA. LentiVector is a registered US and European Community trademark of Oxford BioMedica plc.
Product Information Sheet - I3411
format. Day 1 Plate HEK293T cells (13.5 x 106 cells/flask) in complete DME media 24 hours prior to transfection. Cells should reach 70%-80% confluency the day of transfection. Day 2 1. Thaw the vial
Product Information Sheet - SHC203
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC012
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC014
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC337
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC004
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC009
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC201
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC015
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC003
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC013
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC011
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC317
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC002
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC314
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC005
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
Product Information Sheet - SHC008
the human target, typically 80–90% in A549 cells, a human epithelial lung carcinoma cell line. 9 Figure 1. TRC1 and TRC1.5 Lentiviral Plasmid Vector pLKO.1-puro Features Name Description
1/6